"A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences (NCATS) and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business. The drug c"...
Because this product is not used directly by patients, patient counseling or instructions for use by patients is not considered necessary.
Last reviewed on RxList: 2/1/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Voluven Information
Report Problems to the Food and Drug Administration
Find out what women really need.